Austraian company Dimerix has announced an agreement with UK-based Advanz Pharma to commercialise DMX-200 for a major kidney disease in the European Economic Area, the UK, Switzerland, Canada, Australia, and New Zealand. …
Australian company Dimerix enters agreement to commercialise DMX-200 in major markets
October 6, 2023 Latest NewsBioPharmaAustralian Biotech
Latest Video
New Stories
-
Guilt over this enduring failure is the correct response
September 9, 2026 - -
Poweroos chase world title in Argentina with new backing from Biogen
September 9, 2026 - - Latest News -
What will AI be capable of in two months? We don't know, and that's the point
September 9, 2026 - - Latest News -
'You can't fix a broken system by tinkering with parts of it'
September 9, 2026 - - Latest News -
A review recommendation that should be reconsidered because of time
September 8, 2026 - - Latest News -
The forgotten patients living in the long shadow of rare cancer
September 8, 2026 - - Latest News -
Pharmacists could save women millions and cut GP queues, new analysis shows
September 8, 2026 - - Latest News